Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - Priority Announcement: Global Health Research

University of Calgary

$100,000.00

Middle East Respiratory Syndrome (MERS) seroprevalence in zoonotic reservoirs and in humans: implications for spillover risk and population underlying infection

FY 2023-24

Summary
Middle East Respiratory Syndrome (MERS) is a viral respiratory disease of global importance that is currently mainly transmitted to humans from camels, although it is still unclear how the pathogen spreads and infects individuals across time and geography. Understanding its epidemiologic characteristics via serology (e.g. blood tests that measure the level of antibodies) is key to producing accurate estimates of future animal-human transmission and in turn, implementing public health measures to prevent this risk of "spillover". Barriers to this understanding, however, include the lack of unified and timely serology data, as well as limited awareness of population immunity. To address these barriers, an innovative and continuously updated synthesis and analysis of MERS seroprevalence will be conducted, which will include both academic and non-academic sources. The results will also be visualized on an interactive data web platform. This unique and streamlined approach will in turn inform estimates of MERS prevalence, possible cross-immunity from prior infection/vaccination against COVID-19, and spillover risk, thus facilitating vital insights for use by policy, research and clinical decision-makers in an era of pandemic preparedness. The culmination of this MERS case study will centralize access to MERS serology data, illustrate the feasibility and structure of a unified serosurveillance system, and highlight the design of a tailored data platform for pandemic preparedness. Ultimately, these efforts will build crucial capacity to monitor coronaviruses and other emerging infectious disease threats on a global scale.
Program
Project Grant - Priority Announcement: Global Health Research
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
495102
Name
Arora Rahul K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Public, Community & Population Health 2
Projecttitle
Middle East Respiratory Syndrome (MERS) seroprevalence in zoonotic reservoirs and in humans: implications for spillover risk and population underlying infection
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Global Health Research
Keyworddelim
Data Platform; Living Systematic Review; Middle East Respiratory Syndrome; One Health; Pandemic Preparedness; Seroepidemiology; Seroprevalence; Statistical Modeling; User Interviews; Zoonosis
Abstract
Middle East Respiratory Syndrome (MERS) is a viral respiratory disease of global importance that is currently mainly transmitted to humans from camels, although it is still unclear how the pathogen spreads and infects individuals across time and geography. Understanding its epidemiologic characteristics via serology (e.g. blood tests that measure the level of antibodies) is key to producing accurate estimates of future animal-human transmission and in turn, implementing public health measures to prevent this risk of "spillover". Barriers to this understanding, however, include the lack of unified and timely serology data, as well as limited awareness of population immunity. To address these barriers, an innovative and continuously updated synthesis and analysis of MERS seroprevalence will be conducted, which will include both academic and non-academic sources. The results will also be visualized on an interactive data web platform. This unique and streamlined approach will in turn inform estimates of MERS prevalence, possible cross-immunity from prior infection/vaccination against COVID-19, and spillover risk, thus facilitating vital insights for use by policy, research and clinical decision-makers in an era of pandemic preparedness. The culmination of this MERS case study will centralize access to MERS serology data, illustrate the feasibility and structure of a unified serosurveillance system, and highlight the design of a tailored data platform for pandemic preparedness. Ultimately, these efforts will build crucial capacity to monitor coronaviruses and other emerging infectious disease threats on a global scale.
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Arora, Rahul K
Approvedterm
1 an 0 mois
Cihrcontribution2
CRPPHE~ $100,000~ $0~
University of Calgary - $100,000 Grant (2023-24) | Canada Spends